Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer

38Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Gastric cancer is one of the most common malignancies worldwide; however, the molecular mechanism in tumorigenesis still needs exploration. BCL2L11 belongs to the BCL-2 family, and acts as a central regulator of the intrinsic apoptotic cascade and mediates cell apoptosis. Although miRNAs have been reported to be involved in each stage of cancer development, the role of miR-24 in GC has not been reported yet. In the present study, miR-24 was found to be up-regulated while the expression of BCL2L11 was inhibited in tumor tissues of GC. Studies from both in vitro and in vivo shown that miR-24 regulates BCL2L11 expression by directly binding with 3′UTR of mRNA, thus promoting cell growth, migration while inhibiting cell apoptosis. Therefore, miR-24 is a novel onco-miRNA that can be potential drug targets for future clinical use.

Cite

CITATION STYLE

APA

Zhang, H., Duan, J., Qu, Y., Deng, T., Liu, R., Zhang, L., … Ba, Y. (2016). Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer. Protein and Cell, 7(2), 141–151. https://doi.org/10.1007/s13238-015-0234-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free